Biology of Blood and Marrow Transplantation
Volume 15, Issue 10 , Pages 1239-1243 , October 2009

Targeting Treg Cells In Situ: Emerging Expansion Strategies for (CD4+CD25+) Regulatory T Cells

Received 5 May 2009 ,Accepted 12 June 2009.

References 

  1. Godfrey WR, Ge YG, Spoden DJ, et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood. 2004;104:453–461
  2. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001;193:1295–1302
  3. Hoffmann P, Eder R, Kunz-Schughart LA, et al. Large-scale in vitro expansion of polyclonal human CD4 + CD25high regulatory T cells. Blood. 2004;104:895–903
  4. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493–3499
  5. Turnquist HR, Raimondi G, Zahorchak AF, et al. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4 + T cells, but enrich for antigen-specific Foxp3 + T regulatory cells and promote organ transplant tolerance. J Immunol. 2007;178:7018–7031
  6. Putnam AL, Brusko TM, Lee MR, et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 2009;58:652–662
  7. Earle KE, Tang Q, Zhou X, et al. In vitro expanded human CD4 + CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol. 2005;115:3–9
  8. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med. 2004;199:1455–1465
  9. Cohen JL, Trenado A, Vasey D, et al. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196:401–406
  10. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25 + CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198:235–247
  11. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4 + CD25 + Foxp3+ regulatory T lymphocytes. Nat Med. 2008;14:88–92
  12. Chai JG, Coe D, Chen D, et al. In vitro expansion improves in vivo regulation by CD4 + CD25+ regulatory T cells. J Immunol. 2008;180:858–869
  13. Sega EI, Leveson-Gower D, Nguyen VH, et al. Functional comparison of freshly isolated and ex-vivo expanded CD4 + CD25 + Foxp3+ regulatory T cells in suppressing murine acute GvHD. ASH Annu Meet Abstrs. 2008;112:812
  14. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336
  15. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007;445:766–770
  16. Hoffmann P, Eder R, Boeld TJ, et al. Only the CD45RA+ subpopulation of CD4 + CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood. 2006;108:4260–4267
  17. Hoffmann P, Boeld TJ, Eder R, et al. Loss of FOXP3 expression in natural human CD4 + CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol. 2009;39:1088–1097
  18. Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med. 2007;204:1543–1551
  19. Barao I, Hanash AM, Hallett W, et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4 + CD25+ regulatory T cells. Proc Natl Acad Sci USA. 2006;103:5460–5465
  20. Barnett B, Kryczek I, Cheng P, et al. Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol. 2005;54:369–377
  21. Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest. 2005;115:3623–3633
  22. Mahnke K, Schonfeld K, Fondel S, et al. Depletion of CD4 + CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int J Cancer. 2007;120:2723–2733
  23. Litzinger MT, Fernando R, Curiel TJ, et al. IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 2007;110:3192–3201
  24. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–197
  25. Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol. 2003;33:626–638
  26. Beyersdorf N, Ding X, Blank G, et al. Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody. Blood. 2008;112:4328–4336
  27. Lan YY, Wang Z, Raimondi G, et al. “Alternatively activated” dendritic cells preferentially secrete IL-10, expand Foxp3 + CD4 + T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol. 2006;177:5868–5877
  28. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4 + CD25 + FoxP3+ regulatory T cells. Blood. 2005;105:4743–4748
  29. Kavanagh B, O'Brien S, Lee D, et al. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4 + T cells in a dose-dependent fashion. Blood. 2008;112:1175–1183
  30. Kessel A, Ammuri H, Peri R, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol. 2007;179:5571–5575
  31. Ephrem A, Chamat S, Miquel C, et al. Expansion of CD4 + CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 2008;111:715–722
  32. Boyman O, Kovar M, Rubinstein MP, et al. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 2006;311:1924–1927
  33. Webster KE, Walters S, Kohler RE, et al. In vivo expansion of T reg cells with IL-2 -mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med. 2009;206:751–760
  34. Shatry A, Levy RB. In situ activation and expansion of host Tregs: a new approach to enhance donor chimerism and stable engraftment in MHC-matched allogeneic HCT. Biol Blood Marrow Transplant. 2009;15:785–794
  35. Bayer AL, Jones M, Chirinos J, et al. Host CD4 + CD25 + T cells can expand and comprise a major component of the Treg compartment after experimental HCT. Blood. 2009;113:733–743
  36. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 2001;193:1311–1317
  37. Verbinnen B, Billiau AD, Vermeiren J, et al. Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol. 2008;181:1034–1042
  38. Wilson MS, Pesce JT, Ramalingam TR, et al. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J Immunol. 2008;181:6942–6954
  39. Ahmadzadeh M, Rosenberg SA. IL-2 administration increases CD4 + CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood. 2006;107:2409–2414
  40. Zhang H, Chua KS, Guimond M, et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4 + CD25+ regulatory T cells. Nat Med. 2005;11:1238–1243
  41. Tang Q, Adams JY, Penaranda C, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008;28:687–697
  42. Zorn E, Nelson EA, Mohseni M, et al. IL-2 regulates FOXP3 expression in human CD4 + CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. 2006;108:1571–1579
  43. Zorn E, Mohseni M, Kim H, et al. Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15:382–388
  44. Elpek KG, Yolcu ES, Franke DD, et al. Ex vivo expansion of CD4 + CD25 + FoxP3 + T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol. 2007;179:7295–7304
  45. Pillai AB, George TI, Dutt S, et al. Host natural killer T cells induce an IL-4 dependent expansion of donor CD4 + CD25 + Foxp3 + Tregs that protects against graft-versus-host disease. Blood. 2009;113:4458–4467
  46. Robertson SA, Guerin LR, Bromfield JJ, et al. Seminal fluid drives expansion of the CD4 + CD25 + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod. 2009;80:1036–1045

 Financial disclosure: See Acknowledgments on page 1242.

PII: S1083-8791(09)00294-8

doi: 10.1016/j.bbmt.2009.06.009

Biology of Blood and Marrow Transplantation
Volume 15, Issue 10 , Pages 1239-1243 , October 2009

Article Tools

* Image Usage & Resolution